IBA SA : TRANSPARENCY NOTIFICATION
11 Juillet 2017 - 6:00PM
IBA - TRANSPARENCY
NOTIFICATION
Louvain-la-Neuve,
Belgium, July 10, 2017, 5.40 p.m. - IBA (Ion Beam Applications
SA), the world's leading provider of proton therapy solutions for
the treatment of cancer, announces that it has to issue a
transparency notification, in accordance with Article 14, al. 1 of
the Transparency Law of May 2, 2007 on disclosure of major
holdings, further to the notifications received on 7 July
2017*.
Reason for the notification |
Upwards crossing of the 3% threshold further to the
acquisition of shares -and thus voting rights- held as loan
collateral |
Persons subject to the notification
requirement |
IBA SA, issuer |
Persons that dispose of voting
rights |
Norges Bank |
Transaction date |
|
05/07/2017 |
Threshold that is crossed (in %) |
|
3% (statutory threshold)
Upwards crossing further to the acquisition of voting rights |
Denominator |
|
29 852 549 |
Voting rights (number) |
|
1 015 762 |
Voting rights (%) |
|
3,40% |
Chain of control |
N/A |
About
IBA
IBA (Ion Beam Applications S.A.) is a global medical technology
company focused on bringing integrated and innovative solutions for
the diagnosis and treatment of cancer. The company is the worldwide
technology leader in the field of proton therapy, considered to be
the most advanced form of radiation therapy available today. IBA's
proton therapy solutions are flexible and adaptable, allowing
customers to choose from universal full-scale proton therapy
centers as well as compact, single room solutions. In addition, IBA
also has a radiation dosimetry business and develops particle
accelerators for the medical world and industry. Headquartered in
Belgium and employing about 1,500 people worldwide, IBA has
installed systems across the world.
IBA is listed on the pan-European
stock exchange NYSE EURONEXT (IBA: Reuters IBAB.BR and Bloomberg
IBAB.BB). More information can be found at:
www.iba-worldwide.com
* Erratum on
"7 April 2017" previously communicated.
For further
information, please contact:
IBA
Stephanie
Bauwin
Legal Counsel
+32 10 203 924
Stephanie.bauwin@iba-group.com
20170710 transparency re Norge EN
erratum
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: IBA SA via Globenewswire
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024